Brunetti, O., Badalamenti, G., De Summa, S., Calabrese, A., Argentiero, A., Fucci, L., . . . Silvestris, N. (2019). Molecular Characterization of a Long-Term Survivor Double Metastatic Non-Small Cell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Gefitinib in Combination with Gemcitabine Plus Nab-Paclitaxel and mFOLFOX6 as First and Second Line Therapy. Cancers (Basel).
استشهاد بنمط شيكاغوBrunetti, Oronzo, et al. "Molecular Characterization of a Long-Term Survivor Double Metastatic Non-Small Cell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated With Gefitinib in Combination With Gemcitabine Plus Nab-Paclitaxel and MFOLFOX6 As First and Second Line Therapy." Cancers (Basel) 2019.
MLA استشهادBrunetti, Oronzo, et al. "Molecular Characterization of a Long-Term Survivor Double Metastatic Non-Small Cell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated With Gefitinib in Combination With Gemcitabine Plus Nab-Paclitaxel and MFOLFOX6 As First and Second Line Therapy." Cancers (Basel) 2019.